- Growth of its CorPath GRX robotics system is taking off as physician and patient acceptance is growing, with revenue doubling from a year ago from a small base.
- Growth is likely to continue sequentially on this market acceptance and the company has multiple growth avenues in front of it.
- Especially promising is the exponential growth in demand for cassettes from its growing installed base.
- A path to profitability is present, but there isn’t much hard data to assess its time frame and more dilution seems likely.
Corindus Vascular Robotics Reached An Inflection Point
July 28th, 2019 · No Comments